The European Center for Disease Prevention and Control (ECDC) on Friday raised the risk level for mpox, a day after international health officials confirmed the first infection with a new strain of the virus outside Africa, in Pakistan and Sweden.
The head of the EU’s public health agency said there would be more imported cases of the new strain of mpox in Europe in the coming weeks, although the risk of prolonged transmission remains low.
The World Health Organization on Wednesday declared mpox a global public health emergency, the highest form of alert, after an outbreak in the Democratic Republic of Congo had spread to neighboring countries.
The World Health Organization is to host an emergency meeting on Friday to discuss ways to ensure equitable global access to tests, treatments and vaccines for the virus, a top official said.
Mpox, a viral infection that causes pus-filled lesions and flu-like symptoms, is usually mild but can kill. Two strains are now spreading in the Congo – the endemic form of the virus, clade I, and a new sub-clade called clade Ib.
The ECDC on Friday raised the risk level assessment for mpox to “moderate” from “low” for sporadic cases occurring in the EU and asked countries to maintain high levels of awareness among travelers visiting from affected areas. The agency said the overall risk to the population had increased from “very low” to “low.”
“Because of the close links between Europe and Africa, we need to be prepared for more imported clade I cases,” said director Pamela Reddy Wagner.
Pakistan also confirmed on Friday a case of the mpox virus in a patient who had returned from a Gulf country, although it was unclear whether it was the new variant or the virus that has been spreading globally since 2022.
Mpox is transmitted through close physical contact, including sexual contact, but unlike previous global pandemics such as COVID-19, there is no evidence that it is easily spread through the air.
WHO official Margaret Harris said in a call to media on Friday that she expects more cases outside Africa to appear soon, also as a result of increased surveillance.
However, the WHO has advised against travel restrictions to stop the spread of the virus. China said earlier on Friday that it plans to monitor people and goods entering the country for mpox for the next six months.
DIAGNOSTIC
Far more diagnostic kits, treatments and vaccines need to be sent to Africa to adequately respond to an outbreak of the new strain of the mpox virus there, an official with the humanitarian network of the Red Cross and Red Crescent said on Friday.
The head of global vaccine group Gavi told Reuters it has up to $500 million to spend to get vaccines to countries hit by the escalating epidemic in Africa.
Shares in companies that manufacture and develop products against mpox rose on Friday. Shares in vaccine makers Bavarian Nordic and Emergent BioSolutions rose 20 percent each, while those of Siga Technologies, which makes an mpox antiviral drug, rose 7 percent.
Denmark’s Bavarian Nordic said it has submitted data to the EU medicines regulator for approval to extend the use of its mpox and smallpox vaccine to teenagers aged 12 to 17.
Shares of New Jersey-based Tonix Pharmaceuticals also jumped after the company said it would advance development of its mpox vaccine candidate.
“We are motivated to advance development for our mpox vaccine with urgency given the global public health emergency,” said CEO Seth Lederman.
a href=”https://tribune.com.pk/story/2488621/eu-health-authority-raises-mpox-risk-alert-level-after-first-case-of-new-strain-detected-in-sweden”>Source link


